Journal of Gynecologic Oncology (@jgo_journal) header
Journal of Gynecologic Oncology (@jgo_journal) profile picture

Official publication of the Asian Society of Gynecologic Oncology, Japan Society of Gynecologic Oncology and Korean Society of Gynecologic Oncology

Joined July 2021
Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)Photo by Journal of Gynecologic Oncology (@jgo_journal)
📊 Adjuvant therapy in low-grade endometrioid carcinoma with adnexal involvement? A retrospective SEER study reports 70.6% 5-year OS without adjuvant therapy, highlighting the need for individualized care. Read more: doi.org/10.3802/jgo.2026.37.… #EndometrialCancer
1
186
📢New in #JGO: In 295 Indian women 🇮🇳, first-void urine and self-collected vaginal swabs showed favorable performance for high-risk #HPV testing. First-void urine may offer a non-invasive, acceptable option to help expand #CervicalCancer screening. 🔗doi.org/10.3802/jgo.2026.37.…
2
228
How is hereditary breast and #OvarianCancer care delivered across #Japan? A nationwide survey of 248 institutions found wide variation in testing practices, #GeneticCounseling resources, and post-RRSO management - including STIC. Read the JGO article: doi.org/10.3802/jgo.2026.37.…
1
1
91
📅Save the dates for two upcoming gynecologic oncology meetings: 🔹ASGO 2026 Annual Meeting | Dec 4–6, Shanghai, China 🔹KSGO International Conference 2027 | Apr 2–3, Suwon, Republic of Korea We look forward to connecting with colleagues across the field! #ASGO2026 #KSGO2027
79
📑JGO Article Alert Could #surgery improve outcomes in recurrent low-grade serous #OvarianCancer? 🔎 A 152-patient, 31-center study linked secondary #cytoreduction to longer #survival (adjusted HR 0.28; p<0.001), with complete resection in 92%. ➡️doi.org/10.3802/jgo.2026.37.…
3
180
📢New in #JGO Can neoadjuvant chemotherapy followed by radical surgery be an option for node-positive locally advanced #CervicalCancer? In 97 patients with FIGO IIIC1–2 disease: 🔹5-year OS: 61.1% 🔹5-year PFS: 58.5% ➡️doi.org/10.3802/jgo.2026.37.…⬅️ #GynecologicOncology #CCRT
2
402
📢New in #JGO: In stage IIICr #CervicalCancer without parametrial involvement, primary #chemoradiation showed better #PFS than radical #hysterectomy with lymphadenectomy, especially for tumors ≥4 cm ➡️ejgo.org/DOIx.php?id=10.3802…
2
1
5
530
🌟JGO Best Reviewer Recognition 2026🌟 Congratulations to our outstanding reviewers: 🏅 Jumpei Ogura, M.D., Ph.D. Kyoto University 🏅 Yoko Furutake, M.D., Ph.D. Rakuwakai Otowa Hospital Thank you for your valuable contributions to #JGO🙏 #GynecologicOncology #JSGO2026
🤖 Made with AI
1
177
🆕 New Article in JGO 📊 In a prospective UK #biobank analysis, higher triglyceride-glucose (TyG) and TyG-BMI indices were associated with increased #EndometrialCancer risk, highlighting the potential role of #insulin resistance. 🔗ejgo.org/DOIx.php?id=10.3802…
1
127
New in #JGO: #SWOG S1609 DART reports #VaginalCancer subcohort results for #ipilimumab + #nivolumab. In 7 patients, dual ICI showed #ORR 29% and CBR 43%, with durable responses and no new safety signals. 🧬 Read➡️ejgo.org/DOIx.php?id=10.3802…
1
3
2
336
New article in #JGO: Fan & Fu map cross-country inequalities in the global burden of #CervicalCancer using GBD 2021 data and frontier analysis. Disparities are widening in low-SDI regions. ➡️ejgo.org/DOIx.php?id=10.3802…
127
🆕Pediatric non-gestational choriocarcinoma (PNGC) remains a rare & aggressive disease🧬 In a 74-patient review, comprehensive multimodal therapy improved #survival, while single/no treatment was linked to poor outcomes (3-year OS: 50.8%) ⚕️📊🎯 🔗ejgo.org/DOIx.php?id=10.3802…
55
🧬New Review in #JGO! Discover the evolving concepts of #FallopianTube lesions and their role in #OvarianCancer pathogenesis. From SCOUTs to STICs, explore key histopathological & molecular insights🔬 Read here 👉 ejgo.org/DOIx.php?id=10.3802…
1
69
Trastuzumab deruxtecan (#TDXd) shows durable responses in HER2+ #GynecologicCancers💪, with highest benefit in IHC 3+ tumors. ORRs: #endometrial 57.5%, #cervical 50%, #ovarian 45% 📊. Safety profile consistent✅. Read more: ejgo.org/DOIx.php?id=10.3802… #GynOnc #HER2 #Oncology
63
🎓Inaugural #ASYGO session at #ASGO2025! Young #GynecologicOncologists discussed Rapid #MIS growth but training gaps remain Limited hands-on & #robotic experience Call for standardized, competency-based curricula & cross-border mentorshipship Read more: ejgo.org/DOIx.php?id=10.3802…
101
📣Excited to share that #ASGO2026 - the Annual Meeting of the Asian Society of Gynecologic Oncology - is happening Dec 4-6 at the #Shanghai International Conference Center in #China! 🇨🇳 Visit 👉 apollo10-asgo2026.org/ #ASGO @ASGOLearninghub @KSGO_org #JSGO #GynecologicOncology
1
90
How do #Korean #oncologists use #radiotherapy for recurrent #OvarianCancer? A survey of 116 gynecologic and radiation oncologists reveals differences in goals, patient selection, and SABR use, highlighting the need for standardized guidelines. Read more: ejgo.org/DOIx.php?id=10.3802…
117
Does adjuvant radiation modality matter in FIGO stage I clear cell & papillary serous #EndometrialCancer? SEER analysis shows #brachytherapy associated with superior survival vs. #EBRT (HR 0.44 at 5 yrs; 0.40 at 10 yrs), with 5-yr OS ~81% 👉Read more: ejgo.org/DOIx.php?id=10.3802…
259
📢Article Alert How long does chemotherapy-induced peripheral #neuropathy last in #GynecologicCancer survivors? New evidence suggests symptoms improve but may not fully resolve even after 5 years. Full study ejgo.org/DOIx.php?id=10.3802… #GynecologicOncology #CIPN
4
1
17
12,129
Journal of Gynecologic Oncology retweeted
A MUST-READ! This is probably one of my most important papers where I try to teach how to fish rather than offer fish. How I Read a Clinical Trial Report? BG’s primer for Busy Clinicians. Thank you @JCOOP_ASCO @EthicsdoctorP for the kind invitation. I hope the readers will find this useful. ascopubs.org/doi/10.1200/OP-…
15
374
26
1,233
285,064